Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease

The Clinical Dementia Rating (CDR): Current version and scoring rules

Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075

Apolipoprotein E: Far More Than a Lipid Transport Protein

Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836

Membrane lipid composition and cellular function.

Spector, A. A., & Yorek, M. A. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34276-0 · Cited by 1,495

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363

Oxidative stress and Alzheimer disease

Christen, Y. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,176

Lipid rafts: bringing order to chaos

PIKE, L. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200021-jlr200 · Cited by 1,139

Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples

Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,126

Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease

Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., Troncoso, J. C., & Mattson, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305799101 · Cited by 1,008

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937

Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics

Han, X., & Gross, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300004-jlr200 · Cited by 914

Electrospray mass spectrometry of phospholipids

Pulfer, M. K., & Murphy, R. C. (2003) · Mass Spectrometry Reviews · doi:10.1002/mas.10061 · Cited by 909

Alzheimer's Disease--Genotypes, Phenotype, and Treatments

Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 879

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802

Oxidative Alterations in Alzheimer's Disease

Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789

A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide

Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781

Ceramide in the eukaryotic stress response

Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727

Alzheimer’s disease: the cholesterol connection

Puglielli, L., Tanzi, R. E., & Kovacs, D. M. (2003) · Nature Neuroscience · doi:10.1038/nn0403-345 · Cited by 677

Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype

Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657

APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626

Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability

Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624

Cerebral amyloid deposition and diffuse plaques in ``normal'' aging: Evidence for presymptomatic and very mild Alzheimer's disease

Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996) · Neurology · doi:10.1212/wnl.46.3.707 · Cited by 603

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 571

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00128-6 · Cited by 555

Apolipoprotein E and Alzheimer's disease

Strittmatter, W. J., & Roses, A. D. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.000413 · Cited by 477

Inflammatory processes in Alzheimer's disease

McGeer, E. G., & McGeer, P. L. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00124-6 · Cited by 475

ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition

DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A. K., Aronow, B. J., Bales, K. R., Paul, S. M., et al. (2004) · Neuron · doi:10.1016/s0896-6273(03)00850-x · Cited by 459

Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change

DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405

Intracellular signal transduction pathways activated by ceramide and its metabolites

Ruvolo, P. P. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00050-1 · Cited by 356

A possible role for plasmalogens in protecting animal cells against photosensitized killing.

Zoeller, R. A., Morand, O. H., & Raetz, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38000-1 · Cited by 348

Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome)

Heymans, H. S. A., Schutgens, R. B. H., Tan, R., van den BOSCH, H., & Borst, P. (1983) · Nature · doi:10.1038/306069a0 · Cited by 348

Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis

Bosio, A., Binczek, E., & Stoffel, W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13280 · Cited by 347

Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey

Peters, A., Rosene, D. L., Moss, M. B., Kemper, T. L., Abraham, C. R., Tigges, J., & Albert, M. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00001 · Cited by 344

Vesicular neurotransmitter transporters: from bacteria to humans.

Schuldiner, S., Shirvan, A., & Linial, M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.2.369 · Cited by 329

Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II)

Svennerholm, L. T., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 327

Electrochemical processes in electrospray ionization mass spectrometry

de la Mora, J. F., Berkel, G. J. V., Enke, C. G., Cole, R. B., Martı́nez-Sánchez, M., & Fenn, J. B. (2000) · Journal of Mass Spectrometry · doi:10.1002/1096-9888(200008)35:8 · Cited by 326

High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization

Gross, R. W. (1984) · Biochemistry · doi:10.1021/bi00296a026 · Cited by 299

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease

Albers, D. S., & Beal, M. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_16 · Cited by 298

Brain Membrane Phospholipid Alterations in Alzheimer's Disease

Pettegrew, J. W., Panchalingam, K., Hamilton, R. L., & McClure, R. J. (2001) · Neurochemical Research · doi:10.1023/a:1011603916962 · Cited by 292

Chemistry and functional distribution of sulfoglycolipids

Ishizuka, I. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00011-8 · Cited by 289

Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids

Griffiths, W. J. (2003) · Mass Spectrometry Reviews · doi:10.1002/mas.10046 · Cited by 288

Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway

Lee, J.-T., Xu, J., Lee, J.-M., Ku, G., Han, X., Yang, D.-I., Chen, S., & Hsu, C. Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307017 · Cited by 280

Cholesterol and the Biology of Alzheimer's Disease

Wolozin, B. (2004) · Neuron · doi:10.1016/s0896-6273(03)00840-7 · Cited by 275

Ceramide Interaction with the Respiratory Chain of Heart Mitochondria

Di Paola, M., Cocco, T., & Lorusso, M. (2000) · Biochemistry · doi:10.1021/bi9924415 · Cited by 262

Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether

Zoeller, R. A., Lake, A. C., Nagan, N., Gaposchkin, D. P., LEGNER, M. A., & Lieberthal, W. (1999) · Biochemical Journal · doi:10.1042/bj3380769 · Cited by 257

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain

Ginsberg, L., Rafique, S., Xuereb, J. H., Rapoport, S. I., & Gershfeld, N. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00931-f · Cited by 248

Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia

Farooqui, A. A., & Horrocks, L. A. (2001) · The Neuroscientist · doi:10.1177/107385840100700308 · Cited by 245

Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease

Guan, Z., Wang, Y., Cairns, N. J., Lantos, P. L., Dallner, G., & Sindelar, P. J. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00008 · Cited by 236

Plasmenylethanolamine Facilitates Rapid Membrane Fusion: A Stopped-Flow Kinetic Investigation Correlating the Propensity of a Major Plasma Membrane Constituent to Adopt an HII Phase with Its Ability to Promote Membrane Fusion

Glaser, P. E. A., & Gross, R. W. (1994) · Biochemistry · doi:10.1021/bi00185a019 · Cited by 229

Rapid Plasmenylethanolamine-Selective Fusion of Membrane Bilayers Catalyzed by an Isoform of Glyceraldehyde-3-Phosphate Dehydrogenase: Discrimination between Glycolytic and Fusogenic Roles of Individual Isoforms

Glaser, P. E., & Gross, R. W. (1995) · Biochemistry · doi:10.1021/bi00038a013 · Cited by 210

Bioenergetics of secretory vesicles

Njus, D., Kelley, P. M., & Harnadek, G. J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics · doi:10.1016/0304-4173(87)90003-6 · Cited by 209

The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆

Finch, C. E., & Sapolsky, R. M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00053-6 · Cited by 208

Regulation of TRP Channels via Lipid Second Messengers

Hardie, R. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142505 · Cited by 203

Carbonyl Toxicology and Alzheimer's Disease

Picklo, M. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194

A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease

Lahiri, D. K., Farlow, M. R., Sambamurti, K., Greig, N. H., Giacobini, E., & Schneider, L. S. S. (2003) · Current Drug Targets · doi:10.2174/1389450033346957 · Cited by 185

Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study

Pettegrew, J. W., Panchalingam, K., Klunk, W. E., McClure, R. J., & Muenz, L. R. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90152-x · Cited by 183

Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

Butterfield, D. A., Debra Boyd-kimball, A., & Castegna, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01948.x · Cited by 183

The protective role of plasmalogens in iron-induced lipid peroxidation

Sindelar, P. J., Guan, Z.-Z., Dallner, G., & Ernster, L. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00221-4 · Cited by 181

Characterization and Direct Quantitation of Ceramide Molecular Species from Lipid Extracts of Biological Samples by Electrospray Ionization Tandem Mass Spectrometry

Han, X. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5536 · Cited by 180

Apolipoprotein E suppresses glial cell secretion of TNFα

Laskowitz, D. T., Goel, S., Bennett, E. R., & Matthew, W. D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00021-0 · Cited by 175

Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer?s disease

Mulder, C., Wahlund, L., Teerlink, T., Blomberg, M. I., Veerhuis, R., van Kamp, G. J., Scheltens, P., & Scheffer, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0007-9 · Cited by 174

Mitochondria and ceramide: intertwined roles in regulation of apoptosis

Birbes, H., Bawab, S. E., Obeid, L. M., & Hannun, Y. A. (2002) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(01)00026-7 · Cited by 151

Lipid biochemistry: functions of glycerolipids and sphingolipids in cellular signaling

Ghosh, S., Strum, J. C., & Bell, R. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034165 · Cited by 143

Plasmenylcholine and phosphatidylcholine membrane bilayers possess distinct conformational motifs

Han, X., & Gross, R. W. (1990) · Biochemistry · doi:10.1021/bi00472a032 · Cited by 141

Curvilinear regression course of human brain lipid composition changes with age

Rouser, G., & Yamamoto, A. (1968) · Lipids · doi:10.1007/bf02531202 · Cited by 138

Galactolipids are molecular determinants of myelin development and axo-glial organization.

Marcus, J., & Popko, B. (2002) · Biochimica et Biophysica Acta · doi:10.1016/s0304-4165(02)00410-5 · Cited by 131

Modulating Sphingolipid Biosynthetic Pathway Rescues Photoreceptor Degeneration

Acharya, U. R., Patel, S. A., Koundakjian, E. J., Nagashima, K., Han, X., & Acharya, J. (2003) · Science · doi:10.1126/science.1080549 · Cited by 130

Cerebellar atrophy in Alzheimer's disease—clinicopathological correlations

Węgiel, J., Wı́sniewski, H. M., Dziewíatkowski, J., Badmajew, E., Tarnawski, M. J., Reisberg, ‌., Mlodzik, B., de Leon, M. J., & Miller, D. C. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01279-7 · Cited by 127

Mitochondria in Alzheimer's disease

Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126

Novel Role for Apolipoprotein E in the Central Nervous System

Han, X., Cheng, H., Fryer, J. D., Fagan, A. M., & Holtzman, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212340200 · Cited by 126

Apolipoprotein E: a major piece in the Alzheimer's disease puzzle

Cedazo-Mı́nguez, Á., & Cowburn, R. F. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00159.x · Cited by 123

New clues to Alzheimer's disease: Unraveling the roles of amyloid and tau

Yanker, B. A. (1996) · Nature Medicine · doi:10.1038/nm0896-850 · Cited by 120

The biological significance of plasmalogens in defense against oxidative damage

Brosche, T., & Platt, D. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00014-x · Cited by 119

Alzheimer's disease: β‐Amyloid protein and tau

Morishima‐Kawashima, M., & Ihara, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10355 · Cited by 118

Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

Poirier, J. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00007-8 · Cited by 116

Apolipoprotein E, Amyloid, and Alzheimer Disease

Bales, K. R. (2002) · Molecular Interventions · doi:10.1124/mi.2.6.363 · Cited by 114

Phospholipid composition and levels are altered in down syndrome brain

Murphy, E. J., Schapiro, M. B., Rapoport, S. I., & Shetty, H. U. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02205-8 · Cited by 114

Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia

Han, X., Fagan, A. M., Cheng, H., Morris, J. C., Xiong, C., & Holtzman, D. M. (2003) · Annals of Neurology · doi:10.1002/ana.10618 · Cited by 113

Free-Radical-Induced Oxidation of Arachidonoyl Plasmalogen Phospholipids: Antioxidant Mechanism and Precursor Pathway for Bioactive Eicosanoids

Murphy, R. C. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000250t · Cited by 112

Alzheimer’s Disease and the Cerebellum: A Morphologic Study on Neuronal and Glial Changes

Sjöbeck, M., & Englund, E. M. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051260 · Cited by 105

Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action

Menaldino, D. S. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00054-9 · Cited by 100

Cytokines in Sickle Cell Disease

Pathare, A. V., Alkindi, S. S. A., Daar, S., & Dennison, D. (2003) · Hematology · doi:10.1080/10245330310001604719 · Cited by 95

Long‐term potentiation requires activation of calcium‐independent phospholipase A2

Wolf, M. J., Izumi, Y., Zorumski, C. F., & Gross, R. W. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01371-7 · Cited by 92

Yin and Yang: complement activation and regulation in Alzheimer’s disease

Shen, Y., & Meri, S. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.08.001 · Cited by 91

Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.

Cheng, H., Xu, J., McKeel, D. W., & Han, X. (2003) · PubMed · Cited by 90

Membrane Instability, Plasmalogen Content, and Alzheimer's Disease

Ginsberg, L., Xuereb, J. H., & Gershfeld, N. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062533.x · Cited by 89

Modulation of Amyloid Precursor Protein Cleavage by Cellular Sphingolipids*

Sawamura, N., Ko, M., Yu, W., Zou, K., Hanada, K., Suzuki, T., Gong, J., Yanagisawa, K., & Michikawa, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309832200 · Cited by 88

Membrane Components Separate Early-Onset Alzheimer’s Disease From Senile Dementia of the Alzheimer Type

Gottfries, C., Karlsson, I., & Svennerholm, L. T. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002736 · Cited by 85

Galactosphingolipids and axono-glial interaction in myelin of the central nervous system

Bosio, A., Büssow, H., Adam, J., & Stoffel, W. (1998) · Cell and Tissue Research · doi:10.1007/s004410051051 · Cited by 81

Peroxisomal Impairment in Niemann-Pick Type C Disease

Schedin‐Weiss, S., Sindelar, P. J., Pentchev, P. G., Brunk, U. T., & Dallner, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6245 · Cited by 79

Cholesterol

Raffaı̈, R. L., & Weisgraber, K. H. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300007-jlr200 · Cited by 76

Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis

Vit, J., & Rosselli, F. (2003) · Oncogene · doi:10.1038/sj.onc.1207087 · Cited by 76

Acid Sphingomyelinase-derived Ceramide Signaling in Apoptosis

Gulbins, E., & Kolesnick, R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47931-1_12 · Cited by 74

Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques

van Horssen, J., Kleinnijenhuis, J., Maass, C., Rensink, A. A. M., Otte‐Höller, I., David, G., van den Heuvel, L. P. W. J., Wesseling, P., de Waal, R. M. W., & Verbeek, M. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00010-6 · Cited by 73

Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: Implications for the coordinated regulation of glycolysis and membrane fusion

Glaser, P. E. A., Han, X., & Gross, R. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222542999 · Cited by 71

The role of apolipoprotein E in lipid metabolism in the central nervous system

Han, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4009-z · Cited by 69

Lipoproteins and lipid peroxidation in Alzheimer's disease.

Bassett, C. N., & Montine, T. J. (2003) · PubMed · Cited by 67

Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia

Pettegrew, J. W., Klunk, W. E., Kanal, E., Panchalingam, K., & McClure, R. J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02017-9 · Cited by 66

Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia

Fredman, P., Wallin, A., Blennow, K., Davidsson, P., Gottfries, C. G., & Svennerholm, L. T. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb04006.x · Cited by 65

Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease

Chauhan, N. B. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300010-jlr200 · Cited by 64

Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions

Burow, M. E., Weldon, C. B., Collins‐Burow, B. M., Ramsey, N. W., McKee, A. S., Klippel, A., McLachlan, J. A., Clejan, S., & Beckman, B. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9628 · Cited by 63

Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration

Soreghan, B. A., Thomas, S. N., & Yang, A. J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.007 · Cited by 62

The Role of Cholesterol and Statins in Alzheimer's Disease

Miller, L. J., & Chacko, R. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d104 · Cited by 62

Inhibition of peroxyl radical–mediated lipid oxidation by plasmalogen phospholipids and α-tocopherol

Hahnel, D., Beyer, K., & Engelmann, B. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00142-2 · Cited by 60

Magnetic Resonance Spectroscopic Changes in Alzheimer's Diseasea

Pettegrew, J. W., Klunk, W. E., Panchalingam, K., McCLURE, R. J., & Stanley, J. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48480.x · Cited by 59

Monoclonal Antibody to Embryonic CNS Antigen A2B5 Provides Evidence for the Involvement of Membrane Components at Sites of Alzheimer Degeneration and Detects Sulfatides as Well as Gangliosides

Majocha, R. E., Jungalwala, F. B., Rodenrys, A., & Marotta, C. A. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11798.x · Cited by 52

Dramatic increase of α-hydroxyaldehydes derived from plasmalogens in the aged human brain

Weisser, M., Vieth, M., Stolte, M., Riederer, P. F., Pfeuffer, R., Leblhuber, F., & Spiteller, G. (1997) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(97)00089-3 · Cited by 48

Oxidative Mechanisms in β-Amyloid Cytotoxicity

Davis, J. B. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0060 · Cited by 47

Anti-inflammatory effects of sulfatides in selectin-dependent acute lung injury

Mulligan, M. S., Miyasaka, M., Suzuki, M., Kawashima, H., lizuka, M., Hasegawa, A., Kiso, M., Warner, R. L., & Ward, P. A. (1995) · International Immunology · doi:10.1093/intimm/7.7.1107 · Cited by 47

Free Fatty Acids, Neutral Glycerides, and Phosphoglycerides in Transient Focal Cerebral Ischemia

Zhang, J., & Sun, G. Y. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041688.x · Cited by 45

Functional role of phospholipids in the nuclear events

Alessenko, A. V., & Burlakova, E. B. (2002) · Bioelectrochemistry · doi:10.1016/s1567-5394(02)00135-4 · Cited by 44

Cholesterol, Synaptic Function and Alzheimer’s Disease

Koudinov, A. R., & Koudinova, N. V. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43055 · Cited by 43

Nonmonotonic alterations in the fluorescence anisotropy of polar head group labeled fluorophores during the lamellar to hexagonal phase transition of phospholipids

Han, X., & Gross, R. W. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81616-8 · Cited by 40

Possible Link between Lipid Metabolism and Cerebral Amyloid Angiopathy in Alzheimer’s Disease: A Role for High-Density Lipoproteins?

Mulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40

Synaptic Transmission and Cellular Signaling

Holz, R. W., & Fisher, S. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00012-2 · Cited by 40

Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide

Ditaranto-Desimone, K., Saito, M., Tekirian, T. L., Saito, M., Berg, M. J., Dubowchik, G. M., Soreghan, B. A., Thomas, S. N., Marks, N., & Yang, A. J. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00948-6 · Cited by 36

Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease

Mattson, M. P. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53014-2 · Cited by 33

Proton nuclear magnetic resonance studies on the molecular dynamics of plasmenylcholine/cholesterol and phosphatidylcholine/cholesterol bilayers

Han, X., & Gross, R. W. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90362-c · Cited by 33

Reconstitution of membrane fusion between pancreatic islet secretory granules and plasma membranes: Catalysis by a protein constituent recognized by monoclonal antibodies directed against glyceraldehyde-3-phosphate dehydrogenase

Han, X., Ramanadham, S., Turk, J., & Gross, R. W. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00154-0 · Cited by 31

Protein kinase C isoforms and lipid second messengers: a critical nuclear partnership?

Neri, L. M., Borgatti, P., Capitani, S., & Martelli, A. M. (2002) · PubMed · doi:10.14670/hh-17.1311 · Cited by 30

Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease

Farooqui, A. A., & Horrocks, L. A. (1998) · Biochemical Society Transactions · doi:10.1042/bst0260243 · Cited by 28

Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium

Scherrer, L. A., & Gross, R. W. (1989) · Molecular and Cellular Biochemistry · doi:10.1007/bf00223430 · Cited by 27

A turn of the sulfatide in Alzheimer's disease

Irizarry, M. C. (2003) · Annals of Neurology · doi:10.1002/ana.10642 · Cited by 27

Sphingolipids as differential regulators of cellular signalling processes

Pyne, S., Tolan, D., Conway, A.-M., & Pyne, N. J. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250549 · Cited by 26

Cholesterol, a Modulator of Membrane‐Associated Aβ‐Fibrillogenesis

McLaurin, J., Darabie, A. A., & Morrison, M. R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04840.x · Cited by 25

[46] Synthesis and biological activity of glycolipids, with a focus on gangliosides and sulfatide analogs

Ikami, T., Ishida, H., & Kiso, M. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)11105-x · Cited by 20

Chemical and magnetic inequivalence of glycerol protons in individual subclasses of choline glycerophospholipids: implications for subclass-specific changes in membrane conformational states

Han, X., Chen, X., & Gross, R. W. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00019a003 · Cited by 20

Alzheimer's disease: its origin at the membrane, evidence and questions.

Buchet, R., & Pikuła, S. (2000) · Acta Biochimica Polonica · doi:10.18388/abp.2000_3991 · Cited by 20

Sphingolipids In Vascular Biology

Argraves, K. M., Obeid, L. M., & Hannun, Y. A. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_68 · Cited by 20

Sulfated Galactocerebrosides as Potential Antiinflammatory Agents

Marinier, A., Martel, A. M., Banville, J., Bachand, C., Rémillard, R., Lapointe, P., Turmel, B., Ménard, M., Harte, W. E., Wright, J. J. K., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9606960 · Cited by 17

Effect of Lipid Structure on the Capacity of Myelin Basic Protein to Alter Vesicle Properties: Potent Effects of Aliphatic Aldehydes in Promoting Basic Protein‐Induced Vesicle Aggregation

Epand, R. M., Dell, K. R., Surewicz, W. K., & Moscarello, M. A. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06077.x · Cited by 16

Aβ conformational change is central to Alzheimer’s disease

Holtzman, D. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00040-4 · Cited by 10

Sphingomyelin and ceramide in brain aging, neuronal plasticity and neurodegenerative disorders

Mattson, M. P., & Cutler, R. G. (2003) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(03)12006-8 · Cited by 9

Phospholipid composition and levels are not altered in fibroblasts bearing presenilin-1 mutations

Murphy, E. J., Zhang, H., Sorbi, S., Rapoport, S. I., & Gibson, G. E. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00257-4 · Cited by 4

Reflections on the Great Plasmalogen Puzzle: Effector Mediated Signal Transduction Coupled to Glyceride Structures

Rapport, M. M. (1998) · Neurochemical Research · doi:10.1023/a:1022441029834 · Cited by 4

Ceramide-driven stress signals in cancer and aging

Ruvolo, P. P., Johnson, C. R., & Jarvis, W. D. (2003) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(03)12004-4 · Cited by 2

Untitled work

Cole (2000) · doi:10.1002/1097-0029(20000815)50:4

Functions of plasmalogen lipids in health and disease

Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082

Structural and functional roles of ether lipids

Dean, J. M., & Lodhi, I. J. (2017) · Protein & Cell · doi:10.1007/s13238-017-0423-5 · Cited by 706

Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences

Yang, K., & Han, X. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.08.010 · Cited by 620

Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy

Zheng, W., Kollmeyer, J., Symolon, H., Momin, A. A., Munter, E., Wang, E. L., Kelly, S. L., Allegood, J. C., Liu, Y., Peng, Q., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.009 · Cited by 561

Multi‐dimensional mass spectrometry‐based shotgun lipidomics and novel strategies for lipidomic analyses

Han, X., Yang, K., & Gross, R. W. (2011) · Mass Spectrometry Reviews · doi:10.1002/mas.20342 · Cited by 542

Specific changes of sulfatide levels in individuals with pre‐clinical Alzheimer's disease: an early event in disease pathogenesis

Cheng, H., Wang, M., Li, J., Cairns, N. J., & Han, X. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12368 · Cited by 103

What can lipidomics tell us about the pathogenesis of Alzheimer disease?

Xiang, Y., Lam, S. M., & Shui, G. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0207 · Cited by 27

Lipidome alteration as a hallmark and therapeutic target in Alzheimer’s disease

He, S., & Han, X. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00709

Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?

Senanayake, V. K., & Goodenowe, D. B. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.08.003 · Cited by 51

Roles of Cholesterol and Lipids in the Etiopathogenesis ofAlzheimer′s Disease

Rojo, L. E., Sjöberg-Herrera, M. K., Hernández, P., Zambrano, C. A., & Maccioni, R. B. (2006) · BioMed Research International · doi:10.1155/jbb/2006/73976 · Cited by 57